Interestingly, some of the genes identified in symptomatic patients, including PPT2, DNTTIP2, IQCG, and PRDM16, had also been reported earlier in GWAS or transcriptomic analyses in patients with COPD [27], highlighting their potential significance for COPD predisposition. Here, PRDM16 is linked to chronic obstructive pulmonary disease.